Stay updated with breaking news from Analytical Testing Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Clinical Trials Market by Phase (Phase I, Phase II, Phase III, and Phase IV), by Design (Treatment Studies and Observational Studies), by Region – Global Share and Forecast to 2030
LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced a significant enhancement of its capabilities: a 50% expansion and an investment exceeding $2 million in its standalone offering for Analytical Testing Services (ATS) alongside the introduction of new suppository manufacturing capabilities to its contract development and manufacturing (CDMO) portfolio.
/PRNewswire/ -- The "Global Clinical Trials Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. The clinical...
Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The
The Global Clinical Trials Market Size was valued at USD 51.24 billion in 2022 and the worldwide clinical trials market size is expected to reach USD 93.42...